1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane
CAS916729-96-9
1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane (CAS 916729-96-9) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
![Chemical structure of 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane](https://chemsigma.com/chemicalStructure/91/916729-96-9.png)
- CAS No.
- 916729-96-9
Chemical Specifications
Identifiers
| CAS number | 916729-96-9 |
|---|---|
| Product name | 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane |
| Chinese name | 1-己基-3-甲基咪唑双(三氟甲烷磺酰)亚胺盐 |
| Chinese synonyms | 1-辛基-3-甲基-1H-咪唑双(三氟甲磺酰基)亚甲盐 |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane?
The CAS Registry Number of 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane is 916729-96-9.
How can I request a quotation for 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane?
Send an inquiry for 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane (CAS 916729-96-9) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 1-Methyl-3-octyl-1H-imidazolium salt with bis[(trifluoromethyl)sulfonyl]methane
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.